CAS 60239-18-1
:DOTA
Description:
DOTA, or 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid, is a polyaminocarboxylic acid that serves as a chelating agent, particularly in coordination chemistry and radiopharmaceutical applications. Its structure features a cyclic framework with four nitrogen atoms and four carboxylic acid groups, allowing it to effectively bind metal ions, such as gallium, indium, and lutetium. DOTA is known for its stability and ability to form strong complexes, making it valuable in medical imaging and targeted radiotherapy. The compound is typically used in the labeling of biomolecules for positron emission tomography (PET) and single-photon emission computed tomography (SPECT). DOTA's solubility in water and compatibility with biological systems enhance its utility in various biochemical applications. Additionally, its ability to form stable complexes with radionuclides allows for precise targeting in cancer treatment, highlighting its significance in both research and clinical settings. Overall, DOTA is a versatile compound with important implications in the fields of chemistry, medicine, and radiopharmaceutical development.
Formula:C16H28N4O8
InChI:InChI=1/C16H28N4O8/c21-13(22)9-17-1-2-18(10-14(23)24)5-6-20(12-16(27)28)8-7-19(4-3-17)11-15(25)26/h1-12H2,(H,21,22)(H,23,24)(H,25,26)(H,27,28)
InChI key:InChIKey=WDLRUFUQRNWCPK-UHFFFAOYSA-N
SMILES:C(C(O)=O)N1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1
Synonyms:- 1,4,7,10-Tetra(carboxymethyl)-1,4,7,10-tetraazacyclododecane
- 1,4,7,10-Tetraazacyclodecane-1,4,7,10-tetraacetic acid
- 1,4,7,10-Tetraazacyclododecane-N,N′,N′′,N′′′-tetraacetic acid
- 2,2',2'',2'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetrayl)Tetraacetic Acid
- 2-[4,7,10-Tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
- Dota
- NSC 681107
- Tetraxetan
- 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid
- TETRAAZA-12-CROWN-4 TETRAACETIC ACID AMMONIUM SALT (SEE 2923)
- DOTA(M-140)
- 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid >=97.0% (CHN)
- 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrakisacetic acid
- 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID, FREE ACID
- 1,4,7,10-TETRAAZACYCLODODECANE-N,N'',N , N''-TETRAACETIC ACID , (DOTA)
- 2,2',2'',2'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetryl)tetrakisacetic acid
- Tetraxetan/radical
- 2,2',2'',2'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetryl)tetraacetic acid
- TetraxetanuM
- 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraaceticacid,min.98%DOTA
- 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane
- 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID DOTA
- Tetraxetanum (DOTA)
- Tetraxetan/DOTA/1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid
- -1,4,7,10-tetrayl)tetraacetic acid(DOTA)
- TETRAAZA-12-CROWN-4-1,4,7,10-TETRAACETIC ACID
- 4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid
- 1,4,7,10-Tetraazacyclododecan-N,N',N,N'-tetraacetic acid
- 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 12 products.
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid
CAS:Formula:C16H28N4O8Purity:>97.0%(T)Color and Shape:White to Almost white powder to crystalineMolecular weight:404.421,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid, min. 98% DOTA
CAS:<p>1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid, min. 98% DOTA</p>Formula:C16H28N4O8Purity:min. 98%Color and Shape:white pwdr.Molecular weight:404.42Tetraxetan
CAS:<p>Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoi</p>Formula:C16H28N4O8Color and Shape:White Off-White PowderMolecular weight:404.19071Ref: IN-DA00E8U5
1g26.00€5g34.00€10g50.00€1kgTo inquire25g82.00€50g124.00€5kgTo inquire100g201.00€250mgTo inquireDOTA
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Bifunctional DOTA conjugates to peptides and has become an established strategy for constructing target-specific metal containing agents including targeted MRI contrast agents and diagnostic and therapeutic radiopharmaceuticals.<br>References Lewis, M., et al.: Bioconjug. Chem., 9, 72 (1998), Chappell, L., et al.: Bioorg. Med. Chem., 7, 2313 (1999), Prantner, A., et al.: Mol. Imaging, 2, 333 (2003), Allen, M., et al.: Chem. Biol., 11, 301 (2004), Weiner, R., et al.: BioDrugs, 19, 145 (2005), Breeman, W., et al.: Radionuclide Peptide Cancer Therapy, 119 (2006),<br></p>Formula:C16H28N4O8Color and Shape:Light YellowMolecular weight:404.421,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid
CAS:<p>1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) is a metal chelator or radioligand that is used for the diagnosis of cancer. DOTA, as other analogous compounds such as NOTA, TETA and DTPA, has a high affinity for gadolinium and binds to integrin receptors on the surface of cancer cells. It can then be detected by nuclear magnetic resonance spectroscopy or computed tomography. This agent is also used in conjunction with other drugs to treat certain cancers. The most common use of DOTA is as a component of chemotherapy drugs such as docetaxel and cisplatin. DOTA has been shown to be biocompatible with human serum and metabolic response studies have been conducted in animals without any serious side effects. DOTA has shown to be an effective anti-cancer drug for solid tumors in animals and humans with minimal toxicity due to its coordination geometry.</p>Formula:C16H28N4O8Purity:Min. 95%Color and Shape:White PowderMolecular weight:404.42 g/molTetraxetan
CAS:<p>Tetraxetan is a useful organic compound for research related to life sciences. The catalog number is T65143 and the CAS number is 60239-18-1.</p>Formula:C16H28N4O8Color and Shape:SolidMolecular weight:404.42












